Long-term safety and efficacy of dolutegravir and unboosted atazanavir among experienced HIV-infected adults
- PMID: 31764113
- DOI: 10.1097/QAD.0000000000002365
Long-term safety and efficacy of dolutegravir and unboosted atazanavir among experienced HIV-infected adults
Comment on
-
Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy.AIDS. 2019 Jun 1;33(7):1256-1260. doi: 10.1097/QAD.0000000000002188. AIDS. 2019. PMID: 30870194